Farinaz Farrahi
Allergy & Immunology · San Leandro, CANPI 1174661227
Payments from drug & device makers
Across 102 payments — averaging $24.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$730
- Novartis$224
- Boehringer Ingelheim$223
- Regeneron Healthcare Solutions, Inc.$190
- GSK$189
- Amgen$121
- plus $780 from 22 others
What the payments were for
- Food & beverage$2,44299%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 26 | $730 |
| Novartis | 11 | $224 |
| Boehringer Ingelheim | 11 | $223 |
| Regeneron Healthcare Solutions, Inc. | 6 | $190 |
| GSK | 8 | $189 |
| Amgen | 6 | $121 |
| Novo Nordisk | 4 | $95 |
| Sanofi | 3 | $71 |
| Xeris Pharmaceuticals, Inc. | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 2 | $63 |
| Mannkind Corporation | 2 | $59 |
| Radius Health, Inc. | 2 | $57 |
| Lilly USA, LLC | 3 | $53 |
| Ionis Pharmaceuticals, Inc. | 1 | $30 |
| Bayer | 1 | $29 |
| Averitas Pharma Inc. | 1 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Shire North American Group Inc | 1 | $24 |
| Grifols USA, LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Tandem Diabetes Care, Inc. | 1 | $18 |
| Exact Sciences | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| CSL Behring | 1 | $16 |
| Pfizer | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Halozyme Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,457 in reported general payments places this provider in the 45th percentile of 426 allergy & immunology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $13,948 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $7,491 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $5,005 |
| Azelastine Hcl | 120 | $4,685 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 52 | $1,778 |
| BreynaBudesonide/Formoterol Fumarate | 18 | $1,364 |
| Fluticasone Propionate | 75 | $1,151 |
| Montelukast Sodium | 42 | $523 |
| Levocetirizine Dihydrochloride | 24 | $287 |
| Prednisone | 15 | $25 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $189 | $21,43938 claims |
| AstraZenecaSymbicort | $730 | $5,00516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 426 allergy & immunology providers in California.
Other allergy & immunology in San Leandro
- Kenneth KimLong Beach$18.5M
- Purvi MehraSan Diego$6.3M
- Bob GengSan Diego$6M
- Alexander GreinerSan Diego$4.8M
- Tonny TanusBakersfield$4.5M
- Raffi TachdjianSanta Monica$4.2M
- Vinay MehtaLaguna Niguel$3.3M
- Alan GoldsobelSan Jose$3.3M
- Steven WeinsteinHuntington Beach$3M
- James WolfeSan Jose$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.